Aye Finance Q1 PAT more than doubles YoY to ₹74.5 Cr as credit costs, opex leverage improve
PAT +143.5% YoY · revenue +17.7% · margins expanding
₹477.37 Cr
+17.7% YoY
₹74.5 Cr
+143.5% YoY
15.21%
₹3.02
Aye Finance reported standalone Q1 FY27 (Jun-2026) net profit of ₹74.50 Cr, up ~144% from ₹30.59 Cr a year earlier, on revenue from operations of ₹477.37 Cr (+17.7% YoY). The step-change is a margin story, not a topline one: net profit margin widened to 15.22% from roughly 7.4% in the depressed year-ago quarter, as total expenses grew just ~5% (₹373.74→₹392.51 Cr) against ~18% income growth. Impairment on financial instruments actually eased to ₹81.41 Cr (Q1 FY26: ₹86.71 Cr) even as the loan book expanded, confirming the credit-cost normalisation management flagged on the Q4 call — the earlier print had been dragged by industry-wide MFI/micro-business stress. There are no exceptional items, so reported and underlying growth are the same.
Q1 FY-2027 vs prior quarters
No year-ago quarter on record — YoY cells may be blank.
Sequentially the quarter looks softer — revenue from operations fell 7.3% and PAT 13.3% versus Q4 FY26 (₹85.91 Cr) — but that comparison is distorted by Q4's ₹48.01 Cr net gain on fair-value changes (vs ₹5.14 Cr this quarter) and by higher employee costs (₹138.64 Cr, +22% YoY) as the franchise scaled; QoQ NPM slipped only marginally to 15.22% from ~16.2%. The YoY comparison is the cleaner read and it is strong. Operating metrics corroborate: AUM grew 28% YoY to ₹7,329 Cr (+4% QoQ), disbursements +22% to ₹1,219 Cr and new borrowers +38% to 44,736 — squarely inside the 25-30% FY27 AUM guidance given in April. Gross Stage III stood at 4.49%, Net NPA 1.67%, PCR 63.80%, with CRAR a heavily capitalised 42.38% and LCR 269.61%, reflecting the ₹672.24 Cr fresh IPO proceeds (Feb-2026 listing) now fully deployed into the capital base.
The stock went into the print at ₹184.91, up 10.4% over the past month of trading.
Management guides for strong AUM growth of 25-30% in FY27, driven by robust demand from its micro-MSME segment. Profitability is expected to improve significantly, targeting an ROA of 4-4.5%, supported by a reduction in credit costs to 3.5-4% and enhanced operating leverage with the opex ratio guided down to 8.25-8.75%
— This quarter: met
Street has no published Q1 PAT consensus for this recently-listed name; the available FY27 view pencils ~15-20% PAT growth (Univest, target ₹200 vs CMP ~₹166), which this print runs well ahead of — though partly a low-base effect. Against management's own April guidance the quarter is on-track: AUM growth within range, credit costs falling and annualised earnings implying ROA near the guided 4-4.5%. One caveat sits in the covenant annexure — a single NCD (INE501X07588) breached clause 10.3(a) on the PAR-90-plus-write-offs ratio owing to elevated write-offs from sector-wide micro-loan stress, for which a lender waiver was obtained; the concurrent board actions this week (₹200-4,000 Cr NCD issuance plans, ESOP grants) point to continued funding-led expansion.
W1
AUM growth vs 25-30% FY27 guidance — Q1 tracked at +28% YoY; watch disbursement momentum after +22% this quarter
W2
Credit costs / asset quality — Gross Stage III 4.49% and the micro-loan stress that triggered the covenant waiver; ROA trajectory toward guided 4-4.5%
W3
Opex ratio toward guided 8.25-8.75% as employee costs (+22% YoY to ₹138.64 Cr) scale; NPM sustainability above 15%
Standalone only (NBFC-ML; sole Sec-8 subsidiary FAME not consolidated). Limited-reviewed, unmodified. No exceptional items — raw = adjusted. Year-ago (Q1 FY26) column provides YoY base: rev-ops 405.46, PAT 30.59, EPS 1.60. Covenant note: one NCD (INE501X07588) breached clause 10.3(a) PAR90+write-offs/GLP on MFI/micro-business stress; waiver received.
Strong Q1 masks opex drag; guards long-term 28% CAGR thesis
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Maintained all FY27 guides (AUM 25–30%, credit cost 3.5–4%, opex 8.25–8.75%) despite Q1 beat on NIM and upper-end credit cost. Q1 opex miss deferred to Q3–Q4 normalization.
Optimistic
next 1–2 quarters
Very Optimistic
multi-year
Q1 beat on profitability (PAT ₹74.5 Cr) with NIM 15.9% and credit cost at 4.01% improving. However, opex 8.9% missed 8.25–8.75% guidance, and management maintained not raised guidance despite beat—defensive posture signals near-term execution risk. Long-term 27–28% CAGR thesis is credible (2% market penetration, 571 branches, operational leverage), but capital raise will be needed in 2–2.5 years; recent IPO means leverage still low (3.15x) and ROE will rise as debt scales.
₹477.4 Cr
Revenue · +22% YoY₹74.5 Cr
Reported PAT · +144% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Strongest-ever Q1 disbursement at ₹1,219 Cr
MET22% YoY growth, 4% QoQ; Q4 larger (seasonal), Q1 typically weakest
NIM improved 20 bps to 15.9%
METConfirmed, beat guidance of 14.25–14.75% by 115–165 bps
Credit cost 4.01%, on path to 3.5–4% target
METAt upper end of range, improved 29 bps QoQ; management overlay ₹6 Cr masks underlying run-rate
Opex ratio target 8.25–8.75%
OVERSTATEDQ1 at 8.9%, 15–65 bps miss; management defers to Q3–Q4 denominator effect
PAT ₹75 Cr with 144% YoY growth
METDelivered ₹74.5 Cr; QoQ down 13.3% (seasonal), but strong YoY recovery
Earnings quality
What changed since the last call
NIM guidance increased optionality
NeutralQ1 at 15.9% vs guide 14.25–14.75%. Management notes upside possible from lower reversals (slippage declining) & borrowing cost drop (rating upgrade 10–15 bps), but formally maintains band. Opex will drag as mortgage share grows.
Credit cost on track upper end
NeutralDelivered 4.01% vs guide 3.5–4%. Terminal losses 5.5–6% per product; yearly translates to 3.5%. Q1 benefited from base effects. Management expects continued normalization via portfolio maturation, mortgage ramp.
Opex: deferring guide refinement
DowngradeQ1 8.9% vs guide 8.25–8.75%, 15–65 bps miss. Management explains 10% team growth sufficient for 25–30% AUM growth; denominator effect in Q3–Q4 will drive ratio down. Expects refinement by Q2.
AUM growth confidence reaffirmed
NeutralQ1 28% YoY, 4% QoQ within 25–30% FY27 band. 44,000 new borrowers (+38% YoY), total base 6.7 lakhs. No change to guide; on track.
The Q&A
Analysts pressed hard on opex elevation (why 8.9% vs 4–5% MFI? credit underwriting & monitoring cost justify vs LAP on ticket size 3x), NIM guidance conservation (upside to 14.25–14.75%? mortgage drag offset by borrowing cost), credit cost plateau (why 3.5–4% when already at 4.01%? product model terminal losses justify). Management held firm on guides, defensive not capitulating.
Credit cost guidance conservatism — Sajal Raj, Zenflow Finance
AnsweredProduct mix differs. Hypothecation product: terminal losses 5.5–6%, yearly cost ~3.5%. Model rate. Mortgage/LAP similar. Quarter 1 at top of band; should improve by H1.
Customer addition despite tight credit — Sameer Bhise, Dymon Asia
AnsweredMarket enormous, only 2% penetrated. Product tightly integrated to market need (₹1–2L working capital). Distributed across 18 states, not concentrated. Demand resilient.
Management overlay quantification — Shalin Kapadia, IIFL Capital
AnsweredTotal overlay ₹11 Cr on balance sheet (stage 2–3). This quarter ₹6 Cr created. Reported 4.01% includes overlay; normalized ~0.06% benefit.
PAR X sustainability & collection efficiency — Ananga Rana, A91 Partners
Answered7% PAR X will deliver 3.5–4% credit cost and 4.5–5% post-tax ROA. Model supports current level.
Margin guidance vs borrowing cost tailwind — Shrishti Jagati, Ambit
AnsweredMortgage mix shift (lower yield) drags NIM. Lower slippages (reversals), borrowing cost decline, and rating benefit offset. Upside possible but three factors competing.
Opex ratio path to guide band — Umang Shah, Kotak Mutual Fund
Answered10% team growth sufficient for 25–30% AUM growth. Branch expansion not large opex driver. Denominator effect in Q3–Q4 key; expects entry to band by Q3.
Long-term AUM target and product mix — Shalin Kapadia, IIFL Capital
AnsweredMarket gap huge, 2% penetrated. 60–70% hypothecation, 30% Micro LAP, 10% gold/other. No reliance on one product. Gold loan opportunity (10–12% borrowers have gold loans, only tapping 20% with QR codes).
Co-lending and Direct Assignment strategy — Nischint Chawathe, Kotak
AnsweredTicket size ₹1–1.5L too small; co-lending loses economics (keep 20%, processing fee ₹2.5k insufficient). No liquidity need (diversified borrowers). Limit DA to 5–7% long-term strategy.
PAR 90 levels and write-off philosophy — Shrishti Jagati, Ambit
AnsweredHigh collection efficiency post-PAR 90 means reduction needs write-offs (only 5% collection doesn't enable decline). Won't aggressively write off; collect one-third of PAR 90 book.
Competitive threat from digital fintech (Paytm) — Avnish Tiwari, Vaikarya
AnsweredMarket large, 2% penetrated. Overlap small. Fintech loans ₹30–50k vs ₹1.5L. QR penetration only 15–20% of business volume in tier 2–3. Not strong competition now.
Guidance
AUM growth 25–30% FY27
HighQ1 delivered 28% YoY; guide maintained. Market penetration 2%, branch network 571 across 18 states. No operating constraint seen.
NIM 14.25–14.75% FY27
MediumQ1 delivered 15.9% (upside 115–165 bps). Offsetting factors: mortgage ramp (lower yield, drag), lower slippages (reversal benefit, lift), borrowing cost decline (10–15 bps from rating upgrade, lift). Management notes upside possible but formally holds guide.
Credit cost 3.5–4.0% FY27
HighQ1 at 4.01% (top of band). Management overlay ₹6 Cr this quarter for cross-cycle smoothing. Terminal losses 5.5–6% per product; yearly 3.5%. Confidence high on continued normalization.
Opex ratio 8.25–8.75% FY27
MediumQ1 at 8.9% (miss 15–65 bps). Management expects Q1–Q2 above band, Q3–Q4 inside via denominator effect. 10% team growth tied to 25–30% AUM growth; leverage thesis holds.
Branch expansion 40–50 additions FY27
HighCurrently 571 branches (18 states). Strategy: 10% net addition annually (~40 new branches). Also split branches reaching ₹20+ Cr AUM (44 splits last year, both profitable from day 1). Modest capex impact.
Risks the call surfaced
Operational leverage/Opex scaling
MediumOpex ratio 8.9% vs guide 8.25–8.75%. Management claims denominator effect will normalize, but execution risk if team growth >10% or revenue ramps slower than AUM growth.
Asset quality (Mortgage portfolio)
MediumMortgage PAR 90 5.35% vs hypothecation 3%; gap 2.5% concentrated in 2 states. Newer portfolio (3 years old), collection infrastructure still being built. Recovery rates lower vs hypothecation.
Macro / Monsoon impact
LowMonsoon below normal (92% LTA ±5%); impact concentrated in central India & south peninsula. North (rain-fed tier 2–3 markets, 18+ states) expected resilient. Large states (Bihar, UP, Rajasthan) account for significant portfolio, not monsoon-affected.
Credit cost assumptions
LowManagement assumes terminal losses 5.5–6% across products, translates to 3.5–4% yearly credit cost. If delinquency worsens (recession, rural distress) or recovery rates fall, credit cost will exceed guide.
Market penetration & scale risk
Medium5-year AUM target ₹24,000 Cr (27–28% CAGR from ₹7.3k Cr today) assumes market penetration scales from 2% without major competitive entrant disruption. Execution risk if fintechs, MFI, banks intensify micro-MSME focus.
Management
Score 7/10. Granular, prepared, transparent on overlays and product-wise breakdowns. Provides detailed PAR, collection efficiency, product mix data. Slightly defensive on near-term misses (opex, NIM guide). Six quarters consecutive NPA improvement, credit cost declining toward 3.5–4% target, AUM growth 28% YoY on track for 25–30% guide. Mortgage portfolio new but scaling collections. On track vs prior guides.
1 · Q2 FY27
Monsoon clarity, guidance refinement expected by mid-Q2
2 · Q3 FY27
Opex ratio expected to fall into 8.25–8.75% band as AUM growth accelerates
3 · FY27 full year
Credit cost target 3.5–4% delivery; mortgage PAR 90 collection ramp to reduce gap vs hypothecation
Long-term 27–28% CAGR thesis is credible (2% market penetration, 571 branches, operational leverage), but capital raise will be needed in 2–2.5 years; recent IPO means leverage still low (3.15x) and ROE will rise as debt scales.
Strong Metrics Mask Fee Drains; Guidance Held as Management Signals Caution Ahead
AYE's Q1 PAT jumped 144% YoY with NIM beating guidance by 115 bps, yet management held all FY27 guides firm. Adjusted for one-time fee drains and a weak prior base, the organic story is solid but not exceptional—the market's 6.3% sell-off by day 5 reflects that gap.
₹74.5 Cr
+144% YoY (but Q1 FY26 was a depressed base)
₹20 Cr
Q4 FY26 had DA income; Q1 had none (IPO capital obviated need)
₹32–33 Cr
Broader than DA; structural drag as IPO tail-winds fade
15.9%
Beat 14.25–14.75% by 115 bps; portfolio quality improving
AYE's Q1 is a report card that hit the high bar without signalling upside to management. Reported PAT of ₹74.5 Cr is striking on the headline—144% YoY—yet the company held all FY27 guidance rather than lifting it. The 6.3% sell-off by day 5 reflects this gap: beat the near-term number, but no surprise from management's vantage. That disconnect is the real story.
Where the profit came from (and what it masks)
The 144% YoY PAT jump sits on two pillars that matter less than they appear. First, Q1 FY26 was a depressed base—an easy comp. Second, this quarter's profit is hit by one-time fee pulls: ₹20 Cr in Direct Assignment income that was present in Q4 FY26 but absent here (IPO capital obviated the need to sell assets), and a broader ₹32–33 Cr QoQ decline in fee income reflecting the fade of FY26's end-of-year tailwinds. Adjusted for these, organic PAT would be materially lower, masking the true credit-driven run-rate. Forex P&L (₹12 Cr gain in Q4) also moved to OCI, removing another one-time benefit from the profit line. The core story—NIM beat, credit cost controlled, AUM growth on track—is solid; the headline PAT is inflated by noise.
Strongest-ever Q1 disbursement, ₹1,219 Cr
Confirmed 22% YoY, 4% QoQ; Q1 is seasonally weakest quarter
Supported
NIM improved 20 bps to 15.9%, beat guidance
Confirmed; beat 14.25–14.75% by 115–165 bps (substantial upside)
Supported
Credit cost 4.01% on path to 3.5–4% target
At upper end of range, improved 29 bps QoQ; ₹6 Cr overlay this quarter masks run-rate of ~3.95%
Supported
Opex ratio target 8.25–8.75%
Q1 delivered 8.9%, a 15–65 bps miss; normalization promised for Q3–Q4
Overstated
PAT ₹74.5 Cr, 144% YoY growth
Confirmed ₹74.5 Cr; YoY boosted by low prior base; QoQ down 13.3% seasonal
Supported with caveats
What changed on this call
No major strategic shifts. Management reiterated its 5-year roadmap: ₹24,000 Cr AUM at 27–28% CAGR, fuelled by 2% market penetration in micro-MSME, 571-branch network, and an intentional ramp of mortgages from 22% to 30% of the portfolio. The mortgage segment (3 years old) is showing collection infrastructure gains but still carries elevated PAR 90 (5.35% vs hypothecation's 3%), concentrated in 2 states. Most telling: all FY27 guidance was maintained, not raised, despite PAT beating on the downside and NIM beating on the upside. This defensive stance signals management's confidence in the numbers is guarded—near-term execution risk is visible to them.
NIM beat 15.9% vs 14.25–14.75% by 115 bps; management notes declining reversals (slippage) and borrowing cost benefit (rating upgrade 10–15 bps) still mostly ahead
AUM growth 28% YoY on track for 25–30% FY27 guide; 6.7 lakh active borrowers, 44k new adds (+38% YoY) despite tightened 55%→45% approval ratio
Credit cost 4.01% at upper end of 3.5–4% band; sixth consecutive quarter of NPA improvement (4.49%, down 28 bps QoQ); collection efficiency 99.2% non-OD is durable
Opex 8.9% missed 8.25–8.75% band; branch build and mortgage infrastructure the drivers—but Q3–Q4 normalization is a commitment, not yet a fact
Fee income headwind (₹32–33 Cr QoQ) from DA cliff and IPO tail-wind fade; structural drag into FY27 vs FY26 close
Mortgage portfolio PAR 90 5.35% (vs hypothecation 3%); delinquency concentrated in 2 states but signals collection teams still ramping
Management overlay ₹6 Cr this quarter (₹11 Cr total on balance sheet); cross-cycle smoothing shows discipline but flags latent caution on asset quality trajectory
Guidance held (not raised) despite NIM beat—read as: this quarter is high-bar execution for management's model, not a new normal
How the street is positioned (and why day-5 selloff sticks)
Result announced Wed Jul 22 at pre-result close ₹177.22. Market response: day-1 drop of 3.63%, which widened to 5.87% by day 3 and settled at 6.3% by day 5. That pullback stuck—volume is now decreasing, RSI at 46.9 (neutral, not panic), and the stock trades at ₹166.52, down 15.55% from its all-time high of ₹197.19 but still +88.76% off the 52-week low of ₹88.22. The technical read is that the pop-and-fade is complete; the market is re-rating on fundamentals, not volatility.
The price action maps cleanly to the fundamental signal: beat on headline profit, but guidance stayed put. For growth stocks, that reads as "no upside from here," triggering institutional re-calibration. Current ownership (most recent Q4 FY26 data) shows FII 18.66% and DII 18.39%; no insider filings highlight promotional aggression on the pop. The volume fade and decreasing trend suggest institutions are stepping back to recalibrate position sizing, not rotating out entirely.
Valuation context: ₹166.52 is below SMA20 (₹169.4) and above SMA50 (₹162), marking a short-term downtrend, though the 52-week picture (up 88.76% from low) shows the underlying thesis has held. The street's likely read: 'Good long-term story, but opex execution and guidance caution warrant a pause here—re-enter on Q3–Q4 data or a clearer margin fix.'
Opex normalization execution (Q3–Q4)
HighIf 8.9% doesn't fall into 8.25–8.75% band by Q3–Q4, margin leverage stalls. FY27 guidance would become a ceiling, capping upside re-rate.
Mortgage PAR 90 (5.35%) concentration in 2 states
HighCollection infrastructure newer (3 years old). If monsoon hits those 2 states or recovery rates fall below model 29–30%, credit cost climbs above 4% target.
Fee income structural cliff (DA + IPO tail-winds)
Medium₹32–33 Cr QoQ decline; DA income ₹20 Cr won't recur. Cross-sell income only ₹9 Cr Q1. Fee drag into FY27 will be structural, capping organic profit leverage.
Market penetration execution (2% TAM)
Medium27–28% CAGR relies on scaling from 2% penetration. If fintech (Paytm, others) or traditional MFI intensify micro-MSME focus, customer additions slow.
Capital raise timing (2–2.5 years ahead)
MediumAt 3.15x leverage, AYE has room to ₹14k Cr AUM (1.5–2 years at guided growth). Dilution inevitable; pricing power depends on momentum remaining intact.
Monsoon impact (Q2 clarity expected)
LowForecast 92% LTA ±5%; portfolio concentrated in non-dependent states (north, Bihar, UP, Rajasthan). Lower impact risk, but management flagged for transparency.
1 · Q2–Q3 opex ratio trend
Single most important data point. If opex drifts toward 8.25–8.75% band by Q3, leverage thesis vindicated and momentum can rebuild. If stays 8.7%+, margin ceiling is the new story.
2 · Mortgage PAR 90 and 2-state collection ramp
Watch for PAR 90 trending toward hypothecation's 3% as newly-built collection teams prove themselves. If gap persists above 2%, credit cost pressure lingers.
3 · New borrower additions and approval rates (Q2)
Can AYE sustain 44k+ quarterly net adds despite 55%→45% approval tightening? Slowdown here flags market saturation or demand deterioration.
4 · Guidance refinement (Q2 or Q3 call)
Will management raise any FY27 guide based on momentum, or hold until late-stage visibility? A raise reverses the sell signal; a hold deepens caution narrative.
5 · FII/DII positioning into Q2 earnings
Volume declining, RSI neutral. Is this a pause or withdrawal? Watch for institutional buyers scaling in on dips (bullish) or continued outflow (bearish).
The debate
The bull case: AYE is a credible micro-MSME franchise with 27–28% CAGR runway (2% market penetration, 571-branch moat, proprietary underwriting). Q1 credit metrics are excellent—NIM beat by 115 bps, AUM growth 28% YoY on track, NPA improving for six straight quarters. Near-term opex miss is Q1 seasonal; by Q3–Q4, denominator effect and automation deliver promised margins. Mortgage ramp to 30% will lower credit cost by ~50 bps. At ₹166, down 15% from ATH, the stock offers risk-reward for patient capital. Street pullback is overcautious.
The bear case: Management beat PAT but didn't raise guidance—red flag for growth investors. Adjusted for DA cliff (₹20 Cr), fee drag (₹32–33 Cr QoQ), and low base, organic PAT is more like ₹60–65 Cr, not ₹74.5 Cr. Opex 8.9% signals structural headwinds (branch build, mortgage infrastructure) that may not normalize fully by Q3–Q4, capping margin leverage. Mortgage PAR 90 (5.35% vs hypo 3%) is concentrated delinquency risk, and collection teams are still proving themselves. Fintech and MFI chasing the same segment could narrow AYE's 2% penetration advantage faster than long-term thesis assumes. The 6.3% sell-off (volume fading, RSI neutral) suggests institutional re-rating is justified—take profits into the bounce.
The honest read: AYE is a steady-state compounder, not a step-change story. Q1 was a good quarter—credit quality firm, AUM growth on track, long-term roadmap coherent—but delivered at the upper bound of ranges (NIM, opex), not a breakout. Maintained guidance is the right move for management (defensive but credible), and the 15% pullback is probably fair re-pricing. The inflection point is Q3–Q4: if opex normalizes into band, bull case strengthens; if it stays high, bear case accelerates. Until then, this is a hold-and-monitor for long-term holders, not a screaming buy or a bail-out.
AYE's Q1 FY27 marks a franchise doing steady work: strong credit metrics, on-track growth, and a leadership executing a believable long-term vision. The reported PAT of ₹74.5 Cr is real, but one-time fee drains (DA cliff, forex timing) and a weak prior-year base inflate the 144% YoY growth. Strip those out, and organic PAT is solid but not exceptional. The opex miss (8.9% vs 8.25–8.75%) is the first post-IPO execution hiccup, and management's promise to normalize by Q3–Q4 will either vindicate or undermine the FY27 outlook.
The market's 6.3% sell-off by day 5 is a rational re-pricing: beat the headline, but maintained guidance signals no upside surprise from management's vantage. For holders, the bet is that opex normalization and mortgage collection ramp into Q2–Q3 earnings will prove management's caution was overcautious. For new buyers, wait for Q3–Q4 data to validate the margin thesis, or scale in on weakness if fundamentals hold.
The number to track: opex ratio by Q3 FY27. If it falls into the 8.25–8.75% band, the bear thesis weakens and momentum rebuilds. If it stays 8.7%+, the story shifts from 'growth with leverage' to 'growth, but margins capped'—and the next 15% drawdown becomes more plausible.